Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T04:01:23.491Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient-Associated Risk Factors for Acquisition of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital

Published online by Cambridge University Press:  02 January 2015

Jo-anne M. Salangsang ,
Lee H. Harrison ,
Maria M. Brooks ,
Kathleen A. Shutt ,
Melissa I. Saul  and
Carlene A. Muto
Jo-anne M. Salangsang*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Pittsburgh, Pennsylvania University of Pittsburgh Medical Center, the Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, Pittsburgh, Pennsylvania
Lee H. Harrison
Affiliation:
University of Pittsburgh Medical Center, the Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, Pittsburgh, Pennsylvania
Maria M. Brooks
Affiliation:
Department of Epidemiology, Graduate School of Public Health, Pittsburgh, Pennsylvania
Kathleen A. Shutt
Affiliation:
University of Pittsburgh Medical Center, the Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, Pittsburgh, Pennsylvania
Melissa I. Saul
Affiliation:
Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
Carlene A. Muto
Affiliation:
Division of Infectious Diseases, Department of Medicine, Pittsburgh, Pennsylvania Department of Infection Control, Pittsburgh, Pennsylvania
*
3601 Fifth Avenue, Falk Medical Building, Suite 3A, Pittsburgh, PA 15213 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

Background.

Determining risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals is important for defining infection-control measures that may lead to fewer hospital-acquired infections.

Objective.

To determine patient-associated risk factors for acquisition of MRSA in a tertiary care hospital with the goal of identifying modifiable risk factors.

Methods.

A retrospective matched case-control study was performed. Case patients who acquired MRSA during hospitalization and 2 matched control patients were selected among inpatients admitted to target units during the period from 2001 through 2008. The odds of exposure to potential risk factors were compared between case patients and control patients, using matched univariate conditional logistic regression. A single multivariate conditional logistic regression model identifying independent patient-specific risk factors was generated.

Results.

A total of 451 case patients and 866 control patients were analyzed. Factors positively associated with MRSA acquisition were as follows: target unit stay before index culture; primary diagnosis of respiratory disease, digestive tract disease, injury or trauma, or other diagnosis compared with cardiocirculatory disease; peripheral vascular disease; mechanical ventilation with pneumonia; ventricular shunting or ventriculostomy; and ciprofloxacin use. Factors associated with decreased risk were receipt of a solid-organ transplant and use of penicillins, cephalosporins, rifamycins, daptomycin or linezolid, and proton pump inhibitors.

Conclusion.

Among the factors associated with increased risk, few are modifiable. Patients with at-risk conditions could be targeted for intensive surveillance to detect acquisition sooner. The association of MRSA acquisition with target unit exposure argues for rigorous application of hand hygiene, appropriate barriers, environmental control, and strict aseptic technique for all procedures performed on such Patients. Our findings support focusing efforts to prevent MRSA transmission and restriction of ciprofloxacin use.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 11 , November 2010 , pp. 1139 - 1147
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Boyce, JM. Methicillin-resistant Staphylococcus aureus: a continuing infection control challenge. Eur J Clin Microbiol Infect Dis 1994;13(1):45–49.Google Scholar
2.Klevens, RM, Edwards, JR, Tenover, FC, McDonald, LC, Horan, T, Gaynes, R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42(3):389–391.Google Scholar
3.Klevens, RM, Morrison, MA, Nadle, J, et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298(15):1763–1771.CrossRefGoogle ScholarPubMed
4.Boyce, JM. Understanding and controlling methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol 2002;23(9):485–487.Google Scholar
5.Boyce, JM. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1990;11(12):639–642.Google Scholar
6.Blot, SI, Vandewoude, KH, Hoste, EA, Colardyn, FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicilhn-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162(19):2229–2235.CrossRefGoogle ScholarPubMed
7.Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis. Clin Infect Dis 2003;36(1):53–59.CrossRefGoogle ScholarPubMed
8.Cosgrove, SE, Qi, Y, Kaye, KS, Harbarth, S, Karchmer, AW, Carmeli, Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26(2):166–174.Google Scholar
9.Davis, KA, Stewart, II, Crouch, HK, Florez, CE, Hospenthal, DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004;39(6):776–782.Google Scholar
10.von Eiff, C, Becker, K, Machka, K, Stammer, H, Peters, G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344(1):11–16.Google Scholar
11.Muller, A, Mauny, F, Talon, D, Donnan, PT, Harbarth, S, Bertrand, X. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006;58(4):878–881.Google Scholar
12.Warren, DK, Guth, RM, Coopersmith, CM, Merz, LR, Zack, JE, Fraser, VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol 2006;27(10): 1032–1040.Google Scholar
13.Fishbain, JT, Lee, JC, Nguyen, HD, et al.Nosocomial transmission of methicillin-resistant Staphylococcus aureus: a blinded study to establish baseline acquisition rates. Infect Control Hosp Epidemiol 2003;24(6):415–421.Google Scholar
14.Marshall, C, Wolfe, R, Kossmann, T, Wesselingh, S, Harrington, G, Spelman, D. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hosp Infect 2004;57(3):245–252.Google Scholar
15.Hashimoto, M, Sugawara, Y, Tamura, S, et al.Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study. BMC Infect Dis 2008;8:155.Google Scholar
16.Moore, C, Dhaliwal, J, Tong, A, et al.Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition in roommate contacts of patients colonized or infected with MRSA in an acute-care hospital. Infect Control Hosp Epidemiol 2008;29(7):600–606.Google Scholar
17.Ibelings, MM, Bruining, HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998;164(6):411–418.Google Scholar
18.Rioux, C, Armand-Lefevre, L, Guerinot, W, Andremont, A, Lucet, JC. Acquisition of methicillin-resistant Staphylococcus aureus in the acute care setting: incidence and risk factors. Infect Control Hosp Epidemiol 20O7;27(6): 733–736.Google Scholar
19.Yount, RJ, Vries, JK, Councill, CD. The Medical Archival System: an information retrieval system based on distributed parallel processing. Inf Process Manag 1991;27:379–389.CrossRefGoogle Scholar
20.Cook, DJ, Kollef, MH. Risk factors for ICU-acquired pneumonia. JAMA 1998;279(20):1605–1606.Google Scholar
21.Rubinstein, E, Kollef, MH, Nathwani, D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(suppl 5):S378–S385.CrossRefGoogle ScholarPubMed
22.Weber, SG, Gold, HS, Hooper, DC, Karchmer, AW, Carmeli, Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9(11):1415–1422.CrossRefGoogle ScholarPubMed
23.LeBlanc, L, Pepin, J, Toulouse, K, et al.Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2006;12(9):1398–1405.CrossRefGoogle ScholarPubMed
24.Tacconelli, E, De Angelis, G, Cataldo, MA, Pozzi, E, Cauda, R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J An-timicrob Chemother 2008;61(1):26–38.CrossRefGoogle ScholarPubMed
25.Laheij, RJ, Sturkenboom, MC, Hassing, RJ, Dieleman, J, Strieker, BH, Jansen, JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292(16):1955–1960.CrossRefGoogle ScholarPubMed
26.Aseeri, M, Schroeder, T, Kramer, J, Zackula, R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008;103(9):2308–2313.CrossRefGoogle ScholarPubMed
27.Cordonnier, C, Buzyn, A, Leverger, G, et al.Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003;36(2):149–158.Google Scholar
28.Owens, RC Jr, Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S19–S31.Google Scholar
29.Merrer, J, Santoli, F, Appere de Vecchi, C, Tran, B, De Jonghe, B, Outin, H. “Colonization pressure” and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21(11):718–723.Google Scholar